- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/73 - CD4
Détention brevets de la classe C07K 14/73
Brevets de cette classe: 289
Historique des publications depuis 10 ans
|
11
|
16
|
23
|
23
|
51
|
35
|
39
|
35
|
32
|
14
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4233 |
27 |
| City of Hope | 982 |
18 |
| Mcmaster University | 795 |
16 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
11 |
| Immatics Biotechnologies GmbH | 1154 |
8 |
| The Trustees of the University of Pennsylvania | 4315 |
5 |
| Memorial Sloan-Kettering Cancer Center | 1913 |
5 |
| Juno Therapeutics, Inc. | 384 |
4 |
| Shattuck Labs, Inc. | 119 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6380 |
3 |
| Board of Regents, The University of Texas System | 5754 |
3 |
| The Johns Hopkins University | 5642 |
3 |
| University of Florida Research Foundation, Inc. | 3994 |
3 |
| Children's National Medical Center | 269 |
3 |
| The Council of the Queensland Institute of Medical Research | 156 |
3 |
| eFFECTOR Therapeutics, Inc. | 68 |
3 |
| International AIDS Vaccine Initiative | 89 |
3 |
| Seattle Children's Hospital (dba Seattle Children's Research Institute) | 182 |
3 |
| Lentigen Technology, Inc. | 100 |
3 |
| 2seventy bio, Inc. | 76 |
3 |
| Autres propriétaires | 158 |